Gene therapy refers to any procedure that aims to treat or
alleviate a disease by genetically modifying the cell of a patient.
In particular, this report presents the global revenue
market share of key companies in Gene Therapy in Oncology business, shared in
Chapter 3.
This report presents a comprehensive overview, market shares
and growth opportunities of Gene Therapy in Oncology market by product type,
application, key companies and key regions.
This study considers the Gene Therapy in Oncology value
generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to
2019 in Section 2.3; and forecast to 2024 in section 10.7.
Ex Vivo
In Vivo
Segmentation by application: breakdown data from 2014 to
2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Diagnostics Centers
Research Institutes
This report also splits the market by region: Breakdown data
in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape
and a corresponding detailed analysis of the major vendor/manufacturers in the
market. The key manufacturers covered in this report: Breakdown data in in
Chapter 3.
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen Biotherapeutics
Tocagen
UniQure
Ziopharm Oncology
In addition, this report discusses the key drivers
influencing market growth, opportunities, the challenges and the risks faced by
key players and the market as a whole. It also analyzes key emerging trends and
their impact on present and future development.
Research objectives
- To study and analyze the global Gene Therapy in Oncology market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
- To understand the structure of Gene Therapy in Oncology market by identifying its various subsegments.
- Focuses on the key global Gene Therapy in Oncology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Gene Therapy in Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the size of Gene Therapy in Oncology submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Spanning over 156 pages “Global Gene Therapy
in Oncology Market Growth (Status and Outlook) 2019-2024” report covers Scope
of the Report, Executive Summary, Global Gene Therapy in Oncology by Players,
Gene Therapy in Oncology by Regions, Market Drivers, Challenges and Trends,
Global Gene Therapy in Oncology Market Forecast, Key Players Analysis, Research
Findings and Conclusion.
Please visit this link for more details: https://www.marketresearchreports.com/lpi/global-gene-therapy-oncology-market-growth-status-and-outlook-2019-2024
Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
For related reports please visit: https://www.marketresearchreports.com/search/site/Gene%2520Therapy
Read our Interactive Market Research Blog
No comments:
Post a Comment
Note: only a member of this blog may post a comment.